These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5151708)

  • 1. Identification of crystalline derivatives of butyrophenones by X-ray diffraction: examination of pure compounds and active substances in pharmaceutical formulations.
    Okkerse E; De Leenheer A; Heyndrickx A
    J Assoc Off Anal Chem; 1971 Nov; 54(6):1406-19. PubMed ID: 5151708
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of phenothiazine derivatives and analogs by x-ray diffraction. II. Active substances in pharmaceutical formulations.
    De Leenheer A; Heyndrickx A
    J Assoc Off Anal Chem; 1971 May; 54(3):633-42. PubMed ID: 4147226
    [No Abstract]   [Full Text] [Related]  

  • 3. [Examination of the stability of chloral hydrate and its preparation by capillary electrophoresis].
    Kakehi K; Nakano M; Nishiura S; Tachibana S; Ishida S; Taneda M
    Yakugaku Zasshi; 1999 May; 119(5):410-6. PubMed ID: 10376001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs.
    Gonnissen Y; Verhoeven E; Peeters E; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 May; 69(1):320-34. PubMed ID: 18248803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental requirements for light-induced reactions in powders investigated by time-resolved X-ray diffraction.
    Davaasambuu J; Durand P; Techert S
    J Synchrotron Radiat; 2004 Nov; 11(Pt 6):483-9. PubMed ID: 15496736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of simple X-ray powder diffraction analysis for counterfeit control--the Viagra example.
    Maurin JK; Pluciński F; Mazurek AP; Fijałek Z
    J Pharm Biomed Anal; 2007 Mar; 43(4):1514-8. PubMed ID: 17127026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of drugs in pharmaceutical dosage forms by X-ray powder diffractometry.
    Phadnis NV; Cavatur RK; Suryanarayanan R
    J Pharm Biomed Anal; 1997 Apr; 15(7):929-43. PubMed ID: 9160259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [X-ray diffraction applied to the study of the structure of pharmacologically active substances].
    Covello M; Silipo C; Vittoria A
    Boll Chim Farm; 1971 Apr; 110(4):183-96 contd. PubMed ID: 5111344
    [No Abstract]   [Full Text] [Related]  

  • 9. Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds.
    Seadeek C; Ando H; Bhattachar SN; Heimbach T; Sonnenberg JL; Blackburn AC
    J Pharm Biomed Anal; 2007 Apr; 43(5):1660-6. PubMed ID: 17270379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of homogeneity with X-ray beams.
    Beretzky A; Joó K; Eros I; Pintye-Hódi K
    Int J Pharm; 2005 Mar; 291(1-2):155-9. PubMed ID: 15707742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
    Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
    J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative analysis of clopidogrel bisulphate polymorphs.
    Koradia V; Chawla G; Bansal AK
    Acta Pharm; 2004 Sep; 54(3):193-204. PubMed ID: 15610616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process.
    Purvis T; Mattucci ME; Crisp MT; Johnston KP; Williams RO
    AAPS PharmSciTech; 2007 Jul; 8(3):E58. PubMed ID: 17915808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of spectrophotometric methods for determination of ceftazidime in pharmaceutical dosage forms.
    Hiremath B; Mruthyunjayaswamy BH
    Acta Pharm; 2008 Sep; 58(3):275-85. PubMed ID: 19103564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dependence of Enslin-count on the viscosity of the fluid component].
    Hüttenrauch R; Benesch I
    Pharmazie; 1971 Jul; 26(7):439. PubMed ID: 5094374
    [No Abstract]   [Full Text] [Related]  

  • 16. [Stability testing of drug substances and preparations, a contribution to drug safety].
    Kny L; Stark A
    Pharmazie; 1983 Oct; 38(10):666-70. PubMed ID: 6657735
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability of almagate and pharmaceutical formulations prepared from it.
    Fábregas JL; Beneyto JE
    Arzneimittelforschung; 1984; 34(10A):1354-7. PubMed ID: 6548919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the stability of a nicotinamido-methylaminopyrazolone (Ra 101).
    Banci F; Del Grande P; Monai A
    Arzneimittelforschung; 1970 Aug; 20(8):1030-2. PubMed ID: 5536495
    [No Abstract]   [Full Text] [Related]  

  • 19. Crystal chemistry of hydroxyapatite deposited on titanium by sputtering technique.
    Ozeki K; Yuhta T; Aoki H; Nishimura I; Fukui Y
    Biomed Mater Eng; 2000; 10(3-4):221-7. PubMed ID: 11202150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.